First Trust Advisors LP Aldeyra Therapeutics, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $1.16 Million - $1.65 Million	-146,320 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $273,580 - $389,144	26,205 Added 21.82%	146,320 $1.66 Million
Q1 2021 May 14, 2021	BUY	$6.53 - $14.42 $171,053 - $377,731	26,195 Added 27.89%	120,115 $1.43 Million
Q4 2020 Feb 02, 2021	SELL	$6.31 - $8.13 $23,801 - $30,666	-3,772 Reduced 3.86%	93,920 $644,000
Q3 2020 Nov 05, 2020	BUY	$4.0 - $7.53 $390,768 - $735,620	97,692 New	97,692 $724,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.